Genetic Selection Debate
A discussion unfolds around the implications of FDA regulations on embryo selection technologies, particularly polygenic scores. Insights reveal a tension between the approval of genetic testing for diseases versus the more controversial selection for traits like height. The conversation also highlights contrasting attitudes toward genetic research in China, suggesting a potential shift in where such advancements may occur.In this clip
From this podcast
Dwarkesh Podcast
Byrne Hobart - Optionality, Stagnation, and Secret Societies
Related Questions